Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Carbon Dioxide | HCID 280 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | N-(tert-butoxycarbonyl)glycine | HCID 78288 | — |
| Reactant | HCID 53950528 | HCID 53950528 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 22876606 | HCID 22876606 | 72.5% |
Reaction Steps
4.2 g (24 mmol) of BOC-glycine were dissolved in 40 ml of N,N-dimethylformamide and treated portionwise with 4.05 g (25 mmol) of 1,1'-carbonyldiimidazole. After completion of the CO2 evolution the solution was stirred at 50° for 20 min. Then, 7.7 g (22 mmol) of (S)-8-trifluoromethyl-12,12a-dihydro-9-oxo-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine were added and the mixture was stirred at 90° overnight. The reaction mixture was concentrated and the residue was dissolved in methylene chloride. By washing, drying and evaporating the organic phase there were obtained 7.82 g (72%) of (S)-1-[5-(N-BOC-aminomethyl)-1,2,4-oxadiazol-3-yl]-8-trifluoromethyl-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one, which was used in the next step without further purification.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05665718 |
|---|
| Source dataset | uspto-grants-1997_09 |
|---|
| ORD ID | ord-8b0529345be8437bbca9d78e1e173085 |
|---|
| Source note | uspto-grants-1997_09 |
|---|